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REGIONAL AND LOCAL DIFFERENCES IN CANCER DEATH RATES.
REFERENCE to the table of incidence of malignant disease in various countries
(TableI) tends to confirm the work ofearlierworkers in thefield ofthedemography
of cancer. These figures, recently published by World Health Organisation
(1952a), are fully standardised, i.e., corrected for age and sex differences in the
population of each country, and so are as comparable one with another as it is
possible to make them. All investigations on these lines during the past half
century have pointed to the same conclusion: that the incidence of malignant
disease is largely conditioned by local factors, and Stocks (1947), after a lifetime
of work on this problem, can do no better than quote Hoffman's (1915) statement
made 40 years ago, that "the local variations in cancer frequency throughout the
world are primarily conditioned by local causes and not by faulty methods of
diagnosis or defective methods of death registration." More recent work by
Stocks (1950) and by Legon (1951, 1952) has given further detail to the position in
this country. The present situation has been briefly restated by Stocks (1953) at
Cardiff.
There have been many endeavours to establish a racial factor to account for
the known variations in cancer incidence. Although they have been invariably
inconclusive, as might be expected when consideration is given to the pronounced
differences within individual countries, these surveys have shown that where
racialtypes have migrated to other countries, e.g.,negroesto America, they appear
to take over the incidence of malignant disease of the natural inhabitants among
whom they have come to live. At the International Cancer Conference in London
in 1928, Sourasky (1928) was able to show that although the Jews have certain
cancer characteristics regarding individual organs, their overall mortality from
cancer in different parts of the world varies and tends to approach that of the
non-Jews among whom they come to live. Nordling (1953) comments on the
great difference in the cancer frequency between Whites in the north-eastern
United States and those living in the southern part of the country, as well as
between the negroes in those two parts; and concludes that environment rather
than race appears to be responsible for those differences. This finding has a
further bearing on the data discussed below in the section dealing with the United
States of America.
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Such positive evidence as there is, seems therefore to lend support to the
hypothesis of a geographical rather than a racial factor to account for the observed
variations in the incidence of malignant disease as set out in Table I.
TABLE I.-Standardised figures for Cancer Incidence.
(World Health Organisation.)
Percentage of all deaths statistically attributed to malignant tumours.
1901. 1920. 1947.
European countries.
Germany . . 368 . 5 78 14- 95
England and Wales . . 4.44 . 937 15.06
Belgium . . 3 44 . 538 1012
Denmark . . 10.51 16-19
Scotland . . 4-57 . 8 46 1370
Spain . . . 1-53 . 2 54 5-91
Finland . . . - . 4.49 . 10-09
France . . . . 351 . 471 . 1190
Ireland (Republic of) . 341 5-69 8-99
Italy . . . 240 368 . 8-50
Norway . . . . 639 . 8*58 . 1532
Netherlands . . . 5.44 9.39 16.41
Portugal . . 1-16 . 1.15 3.59
Sweden . . . . . 761 . 8-59 . 12.99
Switzerland . . . . 7-12 . 9.26 15.74
Extra-European countries.
Union of South Africa . . 4.53 . 5.31 . 12.49
Canada . . . . . - . 7-13 . 13.27
Chile . . 104 1.30 4.82
United States . .. 4.05 6.42 13.13
Uruguay . . 3-96 . 524 . 14- 79
Japan . . . . 238 2285 . 4.66
Australia . . . 5-18 . 8.01 . 12.88
New Zealand . . . . 675 8.50 . 14.56
GEOGRAPHICAL SURVEY OF CANCER AND GOITRE INCIDENCE.
Endemic goitre, in varying degrees ofseverity, has a world wide and distinctive
distribution, fundamentally based on iodine distribution or at times on iodine
availability, and it is not difficult to show that iodine deficiency and cancer incid-
ence share much common ground. It must be emphasised that endemic goitre is
no more than a convenient indicator ofiodine deficiency, which in itselfis nowhere
considered as a cause of malignant disease but only as an important contributory
factor in the susceptibility to cancer rather than its cause.
(1) Low countries.
Holland and Belgium are comparable countries of similar size, geographical
aspect, wealth, standard ofliving and racial background. Belgium has however,
acrowdedpopulation offargreaterdensitythanHollandandmuchheavyindustry,
features commonly associated with a high cancer incidence; whereas Holland
has notably less urbanisation and a population that is considerably more agri-
cultural. The cancer incidence of Belgium isonlylO012 and goitre is not common,
except in the south towards the Ardennes and near the Luxembourg border, and
this comparative freedom from goitre is associated with a moderately high contentINFLUENCE OF THYROID IN MALIGNANT DISEASE
of iodine in the drinking water throughout most of the country (McClendon,
1939; Clinquart, 1926). By contrast, Holland has the highest cancer incidence of
any country in the world, 16.41, and a notorious goitre problem that is centuries
old. The accompanying map (Fig. 1) of 1953 indicates in black the areas where
goitre is considered sufficiently common by the authorities to warrant the compul-
sory addition of iodised salt to the bread. Since this map was drawn up last
FIG. 1. Goitre distribution in Holland (Amsterdam University).
year, three further districts have been added to the list in the Northern Province
of Holland (Polak, 1954; personal communication). The lower incidence of
goitre towards the Belgian frontier is apparent and almost certainly significant.
(2) United Kingdom.
Variations of goitre and cancer within the United Kingdom are striking. A
recent survey (Stocks, 1950) of the incidence of carcinoma of the stomach in 83
county boroughs over a period of 18 years showed notable differences "which
cannot be explained by chance variation or by differing accuracy of certification
of cause of death". These variations were shown to correspond to variations in
the hardness ofthe water supply: those with a moderate hardness tended to have
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a lower incidence ofcancer than towns with soft or very hard water. The Medical
Research Council Goitre Survey of the United Kingdom (Murray, Ryle, Simpson
and Wilson, 1948) showed that moderate hardness of drinking water is associated
with less goitre than places with either soft or very hard water.
FIG. 2. Mean cancer incidence for all sites, male and female (after Stocks, 1928).
The same survey showed less goitre in Scotland than in England and this is
reflected in the lower cancer incidence rate for Scotland, ]3-07, as compared with
England and Wales 15.06.
In 1928 a map (Fig. 2) was prepared for the London International Cancer
Conference by Stocks (1928) showing the incidence of cancer of all sites county
by county. A few years later, McEwan (1938) produced a goitre map ofEngland
on a year's figures of deaths from toxic goitre (Fig. 3). Wayne (1954) has shown
that toxic goitre and endemic goitre have similar distribution, and maps drawn
from figures of toxic goitre have much advantage over those made from
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surveys of recruits and schoolchildren, for these are necessarily incomplete and
sporadic, and McEwan's map (Fig. 3) has a close resemblance to other maps of
goitre (Campbell, 1925, 1927; McEwan, 1948). Certain anomalies have arisen,
probably due to taking into account only one year's figures, for Oxfordshire is
shown by Campbell's maps and the recent M.R.C. Survey of Goitre (Murray et
al., 1948) to have a high goitre incidence. This would be in keeping with the
known clinical experience with regard to malignant disease in that county.
Comparing these two maps a striking correlation is at once apparent. Out-
standing arethe heavyincidences ofgoitre and cancer in mid-Wales, Westmoreland
FIG. 3.-Goitre incidence derived from deaths from toxic goitrc (after McEwan, 1938).
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andthe Fen district andneighbouring counties, and by contrast the light incidence
in Yorkshire, Lincolnshire, Herefordshire and Pembrokeshire. Gradations of
correspondence on both maps are evident in comparing Norfolk, Suffolk and
Essex; Kent and Sussex; Cornwall and Devon; Glamorgan and Carmarthen.
(3) Sweden.
A higher death rate from cancer was shown to exist in two Swedish counties,
Kopparberg and Gefieborg, than was found in the total rural areas of Sweden
(Stocks, 1925). Those two counties, as shown by examination of schoolchildren,
recruits for the army and candidates for confirmation, were found to have a higher
incidence of goitre as compared with the rest of the country.
(4) Norway.
Similarly, known goitrous counties in Norway were compared by Stocks (1924)
with counties showing little goitre, and it was found that the goitrous counties
showed a cancer rate for all organs of 113-7 as compared with 94.4 for the niion-
goitrous counties.
(5) Iceland.
In Iceland, the thyroid has been shown to contain one ofthe highest conlcentra-
tions of iodine, and endemic goitre is non-existent (Rundle, 1951). Thyroids
there weigh on an average 14 g. in men and 11-5 g. in women, as compared with
the average of 25 g. in most countries (Kelly, 1946). Now Icelanders are mostly
ofNorwegian stock with some Danish admixture, and cancer incidence in Norway
is 15-32 and in Denmark 16-41, but in Iceland it is only 5-98 (not standardised)
(W.H.O., 1952b).
(6) Spain and Portugal.
Goitre is only mentioned as occurring in one province in Portugal, Alemtejo,
on the southern end of the Spanish border (Kelly, 1946). Goitre is common in
Spain where there has been a goitre commission for many years. The cancer
incidence in Spain is 165 per cent of that found in Portugal.
(7) Switzerland.
Switzerland has always had a notorious goitre problem, but in spite of the
absenceofheavy industry andlarge towns, andinspite ofits reputation for healthy
living conditions, this country has always had a high incidence of malignant
disease. Stocks (1924) found a close statistical relationship between the goitre
rate ofthe various cantons as calculated from figures taken from the examination
of recruits for the army, and carcinoma of the stomach and oesophagus of the
general population. When considered canton by canton, the regression figure is
0-6459 ± 0-0302, or ifthe canton of Ticino is omitted the figure rises to 0-7481 ±
0-0554, whichlifts the correlation wellbeyond the bounds ofmere chance. Taking
into consideration the lightly affected regions as well as the heavily affected ones
it is possible to make out a correlation byinspection, though byno means so clearly
as for England and Wales (Fig. 4, 5).
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(S) (;( Ir atn!.Y
The crudie death rate for carcinoma of the lung among the miners of Schlnee-
bicg' anld Joachimnsthal (vvwhere the radinum for MAadame Curie was first mined) is
23 times-Inot pei cent--that of the general rate for carcinomna of the lIIIg for the
rest of ('ernmany (MAachle and (,regorius, 1948). These miines are fairly close
logetller in one of the four mlain goitre centres of (ernmany on the Erzge)irge
firontier of Saxony and (Czechoslovakia. In these m-ines all the mnineris are presun-
ably equlally at risk fromi the inhaled radio-active material, but by no imeans all
tle menII (levelop cancer of the lung and it is at least open to speculation that the
al)larent iimmunity of a considerable section of the miining comimuniity may be
(Ille to sollme factor associated with the presence or absence of goitre, or alter-
nativeIly to a i)roperly or feebly finctioning thlyroid(l. In this connection it is
plerhal)s worth noting that a high incidence of lung cancer has not. so far as
I al'm awarl.e. l)een reported friom other radio-activ\-e mlines.
(!9) UI.i fltid S ('ats (' f /merl'ic(C .
lie lalrge g(oitlre belt in the U.S.A. across miost of the northern states and
rllininlg so{uth along milch of the Pacific Coast (Fig. 65), first canie to the public
notice dulring the ( teat \Wa whlen, of niearly 1 '2,) len turnIIed dowii for miilitary
service on accoiunit of goitre, some 3,60)) were unable to button the mlilitary tunic
araound thleilr necks on account of the size of their g(oitres (McClendon, 1939). If
lhe forty- large towns and( cities of the U.S.A. are arranged in descending or(ler
40}1
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of their crude death rates for cancer as given by Hoffman (1915) it will be found
that eight ofthe first ten lie in known goitrous areas, and that eight ofthe last ten
(showing the lowest cancer rates) lie in the non-goitrous areas. Stocks (1925)
has showed that there is a statistical correlation, with a regression figure of0.644 ±
0.065, between the incidence of goitre, as recorded by the recruit figures. and
carcinoma of the stomnach and oesophagus, when considering separate states.
(10) Australia and New Zealand.
Australia is considerably more industrialised than New Zealand and has many
large cities as compared with the latter country. Furthermore, rodent ulcer is
infinitely more common in Australia, where goitre does not obtrude as a major
health problem, though there are certain areas where there are definite, if small,
districts where goitre is found (Kelly, 1946). The Australian cancer death rate
is 12.88. The more rural and agricultural population of New Zealand has
a death rate from cancer of 14-56. Here goitre is a major health problem and its
incidence in Europeans, Maoris and animals alike has been closely studied for
years. The Maoris are said to have a word, "tenga ", which has been in their
language for centuries and means goitre (Kelly, 1946).
Fio. 7.-World goitre map (after Kelly, 1946).
(11 ) Japan.
In Japan much seaweed and fish is eaten, and goitre is rarely found except for a
few cases in the central mountain areas (McClendon, 1939). The islands are
densely populated, Tokio and Osaka having greater populations than any town in
the United Kingdom except London, and there is much heavy industry and
generally a low standard of living. These are conditions usually associated with
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a high cancer incidence, but for long Japan has enjoyed one of the lowest cancer
rates of the world, 4-66 in 1947.
This geographical survey lends support to the thesis not only that the general
incidence of malignant disease is to a large extent conditioned by local factors,
but that the one factor in evidence is apparently linked with the availability of
iodine, using goitre as a clinical indicator.
CLINICAL OBSERVATIONS.
A self evident association between cancer and goitre or impaired thyroid
function from the clinical aspect is unlikely to have remained undetected till now.
Althlough the substance of this enquiry took origin from certain clinical observa-
tions, data as clear as the geographical and experimental evidence cannot beex-
pected for some years' time, when the results of the clinical trials and investiga-
tions that have been started become available. There are, however, a number
of observations that, while not fully conclusive, may provide pointers sufficiently
circumstantial to warrant further clinical investigation on the lines outlined here.
(1) The metabolic rate in man decreases progressively with increasing age, and
theincidence ofmalignant disease increases progressivelywith age. The incidence
of malignnat disease thus seems to be correlated with the decrease in metabolic
rate. As metabolic rate is in general a rough indication ofthyroid activity, there
would be appear to be some relationship between malignant disease and thyroid
dysfunction. Thus, the lowered metabolic rate often seen in diabetes mellitus
(Joslin, 1946) may be considered with the increased liability ofdiabetics to develop
carcinoma in any site or organ as compared with non-diabetics (Joslin, 1946).
In the same way, the lowered metabolic rate commonly found in patients with all
types of peptic ulcers (Kolmer, 1949) may be considered with the incidence of
carcinoma of the stomach-still one of the commonest neoplasms of man.
(2) It has long been observed that puberty and pregnancy are periods when
goitres may appear (Marine and Lenhart, 1909; Marine, 1935), and may disappear
when the period of excessive demand ceases or when iodine is given. These are
also the periods when melanomata tend to increase in size and may, not infre-
quently, become malignant. At the beginning ofthis year Mrs. R-wasadmitted
to this hospital on account of malignant melanoma with spread to glands in the
course ofher thirdpregnancy. In her two previous pregnancies she also developed
malignant melanoma on each occasion and was in this hospital in consequence.
She has a moderate enlargement of the thyroid of the smooth "colloid" type
seen commonly in pregnancy. The end of pregnancy is also the period when
chorionic carcinoma and lactation carcinoma of the breast occur-perhaps the
most rapidly growing class of cancer known.
(3) Administration ofthyroid has been found to improve the action of oestro-
gens in the treatment of carcinoma of the prostate, permnitting the effective use
of smaller doses of oestrogen and delaying the onset ofinsensibility to oestrogen
(Winsbury White, 1948). In support of this clinical experience a paper in endo-
crinological research is quoted (Chu and You, 1945), but the final conclusions of
these workers was that the simultaneous administration of oestrogen and thyroid
was the same as that obtained by thyroid feeding alone.
(4) Reduction of keloid formation can often be brought about by administra-
tion of thyroid. A series of such cases is given by Updegraff (1933), all in his
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series showing a low metabolic rate. Although keloids are not neoplasms
in the strict sense of the word, they tend to recur after adequate excision, and
partly ulcerated keloids are prone to undergo carcinomatous change after a period
oftime.
(5) Weights of the thyroid of children coming to autopsy between the ages of
6 and 10 were observed in three European towns, and the cancer incidence of
those noted (Bayard, 1919).
Bern. Munich. Kiel.
Average thyroid weights 18.5 g. 11 9 g. 7-4 g.
Cancer mortality per 100,000 population 132 . 98 . 57
(6) The iodine content of the thyroid has been shown to reach its mnaximum
in the adult and remains fairly contant until the age ofabout 50, after which there
is a gradual decline (Rundle, 1951). The age for the start ofthe decline in iodine
content of the thyroid coincides in general with the age at which malignant
disease in mnan becomes a prominent feature.
(7) In the second week ofJanuary ofthis year there were at least three patients
in this hospital at the same time with gross goitre and cancer.
Mrs. M--, carcinoma of breast and a large colloid goitre visible seven or eight
beds away down the ward.
Mr. E-, lymphosarcoma and a thyroid that weighed 80 g. at autopsyexclud-
ing involvement with growth.
Mr. R-, carcinoma of parotid. The nodular goitre caused some difficulty
during resection ofglands ofneck.
Since January other patients have been seen in the wards of the hospital with
coexistent carcinoma and goitre. It is relevant to note that the area from which
this hospital draws its material, Gloucester, Somerset and Cornwall, is not one in
which goitre is frequent.
(8) The association of goitre and malignant disease in the post-mortem room
was strikingly illustrated by analysis of 1000 post mortems at the Middlesex
Hospital (Stocks, 1924), when anomalies ofthe thyroid were found in 13.3 per cent
ofmales and 21.2 per cent offemales of500 persons dying ofcancer; whereas only
2-0per cent ofmales and 6.5 percent offemales dying ofnon-cancerous conditions
showed anomalies of the thyroid. Professor Barlow excluded from these anoma-
lies secondary invasion of the thyroid by cancer, and the anomalies most fre-
quently found were simple parenchymatous enlargement and adenomatosis, while
calcified nodules, cystic changes, atrophy and fibrosis were frequent. The final
result of the survey showed that thyroid anomalies occurred in 18.7 per cent of
500 persons dying of cancer and only in 3.9 per cent of 500 persons dying of con-
ditions other than cancer. Although Stocks (1954, personal communication) has
recently cast some doubt on the accuracy of the non-cancerous figures while con-
firming the cancerous ones, it would require a considerable error of observation
to influence greatly the 480 per cent preponderance of thyroid anomalies in the
cancerous figures.
The majority of hypo-functioning thyroid glands are small and virtually
impossible to detect on palpation and indistinguishable clinically from normally
functioning glands, and it is common clinical experience that moderately enlarged
thyroids are easily missed even when they are not retrosternal, especially when no
symptoms direct attention to that area ofthe neck. Measurement ofradio-iodine
clearance and of protein bound iodine are therefore essential steps to establish
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dysfunction, and these are now being carried out on a series of patients with
known malignant disease, some of whom have shown unexpectedly low clearance
and P.B.I. values under the age of 50 without other clinical evidence of hypo-
thyroidism. A further series ofpost-operative cases of carcinoma of various sites,
treated with thyroid and other organic iodine preparations is being observed in the
follow-up clinics ofthis hospital, and in due course it should it be possible to report
on the results of these investigations.
ANIMAL EXPERIMENTS.
The influence of thyroid activity on malignant growths in animnals is demon-
strated in the review ofexperimental work quoted here, in which both administra-
tion and deprivation have been used to show its important effect on dependent
neoplasms.
(1) The incidence of successful takes of grafts of granulosa cell tumours,
luteomas and tubular adenomas made into the spleen of mice was noted under
varying conditions.
Successful
"takes." Per cent.
On normal diet . 16 out of 21 . . 76
Same diet plus 0 2 per cent thyroxine 2 out of 20 . . 10
(Miller and Gardner, 1950)
Comment.-The presence of excess of thyroxine in the tissues appears to be
prejudicial to the successful grafting of tumours from one mouse to another.
(2) The incidence of tumours at the site of injection of chemical carcinogens is
reduced by a single injection ofthyroxine, and metabolic studies have shown that
the rate of disappearance of the carcinogen from mice is significantly increased by
thyroxine treatment. Four weeks after injection of 1, 2, 5, 6-dibenzanthracene
into mice treated or untreated with thyroxine, the amount of carcinogen remain-
ing in the carcases, estimated spectroscopically, is significantly lower with thyro-
xine treated animals. Conversely, dibenzanthracene exerts an inhibitory effect
on the toxic effect ofthyroxine with anoxia survivTal tissue as the criterion. When
the dose response curve of mice to the sarcomagenic action of dibenzanthracene
is studied (injections of5, 16, 48 and 1000,tg. ofDBA) it isfound that simultaneous
administration of thyroxine significantly lowers the tumour response. This also
is true if thyroxine is given at different sites in the animal. Thiouracil feeding
markedly increases the incidence of DBA tumours produced by 1 mg. of DBA
(Bather, 1952).
(3) Rats bearing Walker Rat Carcinoma 256 were treated with natural thyro-
xine. Of these 27 per cent showed complete remission and 12 per cent "favour-
able " histological response, 68 per cent. showing no response at all. Another
group treated with synthetic hormone gave only 2 per cent of remissions and no
response in 98 per cent ofanimals. 158 animals were involved (Herbut, Kraemer,
and Jacksen, 1950).
Comment. Regression ofrat tumours may be induced bythyroxine the natural
hormone being superior to the synthetic.
(4) Feeding butter yellow (p-dimethylaminobenzene) to rats produced malig-
nant neoplasms of the liver. The addition of wheat, yeast or casein to the diet
all delayed the onset of tumours as compared with the controls. (Rusch and
Baumann, 1945).
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Comment.-Wheat, yeast and casein are all proteins with moderately high
content of tyrosine, thyroxine being derived by stages from tyrosine and iodine,
tyrosine deficiency being a recognised cause ofhypothyroidism.
(5) A rat thyroid tumour occurred after prolonged methyl thiouracil adminis-
tration. This tumour could be transplanted to another rat provided the second
rat was first rendered thyroid deficient. In the second "take "rats it underwent
anaplastic changes and could then be transplanted into yet other rats without
thyroid deficiency. At this stage the tumour had presumably become auto-
nomous after being dependent. (Purves, Griesbach and Kennedy, 1951).
(6) The course of growth of spontaneously occurring mammary tumours in
mice was observed. Most had multiple tumours. Many grew conspicuously
during pregnancy and regressed after parturition, but recurred promptly when the
mouse became pregnant again. Foulds is convinced that the phenomenon is
hormonal, but the mechanism remained obscure for apparently it is not due to
the action ofprogesterone or oestrogen. (Foulds, 1949).
Comment.--Thyroid deficiency during pregnancy has long been recognised
(Marine and Lenhart, 1909; Marine, 1935) and might well account for the findings
of this experiment.
This review of a selection of experimental work designed to show the action
ofthyroid in tumour production and regression, contributes further support to the
geographical and clinical observations already set out to correlate thyroid defi-
ciency and cancer incidence.
PHYSIOLOGICAL AND PATHOLOGICAL DATA.
Under normal conditions the thyroid is closely associated with (a) Tissue
Oxidation, (b) Growth, (c) Development. These three functions are conveniently
compared with conditions that exist in malignant neoplasms.
Ti8ssue oxidation.
Thyroid stimulates metabolism by increas-
ing oxygen consumption, probably by cata-
lysing the enzyme systems which are respon-
sible for tissue oxidation processes.
Growth.
Thyroid promotes normal growth under
normal physiological conditions.
Development.
Thyroid brings about development and
differentiation of tissue.
Malignant tissues, in comparison with normal
tissues and benign tumours, are characterised
not only by having the lowest concentration
of Cytochrome C, but also by having the
greatest disparity between the components
of the oxidase-cytochrome system. Malig-
nant tissues also show very low amounts of
catalase and of the flavin enzymes and
co-enzymes (Greenstein, 1947).
Most carcinogenic substances, in particular the
potent hydrocarbons but also those of the
urethane group, have been shown to have a
considerable growth restraining influence
(Haddow, 1938).
Histologically, malignant disease tends to show
a dedifferentiation or reversion towards
anaplastic tissue pattern that is often com-
pared to embryonic or foetal type of cell.
DISCUSSION.
It is instructive to put these observations on a footing with the present know-
ledge oftumour regression.
First, it may be recalled that it has been variously estimated that spontaneous
regression of tumnours occurs in man once in about 5000 cases ofmalignant disease.
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This in itselfcommends to many the idea that cancer has a chemical and probably
a hormonal basis, for comparatively sudden changes in the function of endocrine
glands either to the plus or to the minus direction is a familiar observation, and in
particular with regard to the thyroid.
Secondly, it is relevant to note the comparative frequency ofmultiple primary
malignant neoplasms, for this interesting condition suggests that the body can
fairly readily develop a malignant diathesis, and the most likely explanation for
this is a hormonal change, the sites of the primary growths being determined by
siting factors, which are better understood but which are not within the scope of
this present enquiry. A survey by Williamson (1950) of the work of well known
English and Continental morbid anatomists gives a figure of 4 per cent for the
incidence of multiple primary carcinomata of all autopsies of malignant cases.
In view of the comparatively short expectation oflife in the average patient with
cancer this figure of 4 per cent is probably higher than might at first appear, for
the time available to these persons to develop fresh primaries is inevitably short.
Furthermore, when it is remembered how easy it is to regard every mass ofgrowth
both at the bedside and at autopsy, as an" obvious " metastasis, it is perhaps not
altogether surprising thatthisfigure isnothigher. Nevertheless, multiple primary
neoplasms, even apart from mesenchymal tumours, are common experience to
both clinician and morbid anatomist alike, and some would go so far as to think
that their numbers are on the increase, or possibly that they are being recognised
more freely.
TABLE II.-Incidence of Multiple Primary Carcinoma.
(After Williamson, 1950.)
Synchronous double primary carcinomata.
Number of Number of
Number of malignant multiple
Author. necropsies. cases. malignancy.
Halllon .. 3000 . 950 18 (1-9%)
Bilello 8024 . 1154 7 (0.5%)
Bugher . . . 4394 983 . 30 (3'1%)
Austin . . . . 8124 . 887 24 (2'7%) Burke . . 2033 583 . 46 (7.8%)
Tullis . . . 6836 . 1044 . 21 (2'0%)
Warren and Gates . 1075 40 (3.7%)
Warren and Ehrenreich . - . 2829 194 (68%)
Total . . . . . 9495 380
Average rate of multiple primary malignancy = 4 0 per cent.
Unfortunately it is not possible in the present state of knowledge to give any
accurate account of the effect of hormones on the observed temporary regression
of tumours either in man or in animals, for in this field there are too many gaps
in our knowledge, too many uncertainties and a certain residuum of conflicting
evidence. But the results ofadrenalectomy, castration and the administration of
oestrogens and sometimes of androgens, all seem to point to a suppression, if only
temporary, of some ofthe functions ofthe pituitary, at least in man. The recent
work of Moon, Simpson, Li and Evans (1950a, 1950b, 1952a, 1952b) has convinc-
ingly confirmed the conclusions of earlier workers twenty years ago (Ball and
Samuels, 1932; Bischoff, Maxwell and Ullmann, 1934), that whereas extracts
of the anterior pituitary cause tumours to arise in a variety of sites in laboratoryJ. G. C. SPENCER
rodents, extirpation or irradiation of the pituitary will either slow up the rate of
established tumour growth or will effectively inhibit the carcinogenic effect of
such powerful substances as methylcholanthrene. Recently hypophysectoimy
by Luft and Olivecrona (1953) in a series of women with advanced mammnary
carcinoma who had already been treated with every standard surgical hormonal.
and radiation therapy without effect, appears to have reproduced in man the results
observed in animals twenrty years ago.
Attempts to bring about tumour regression by castration or adrenalectomiy are,
for the most part, merely applications of those animal experiments, but acting
through their indirect effect on the pituitary. The administration of oestrogelns
aims at bringing about a partial, if temporary, medical hypophysectomy, though
unfortunately oestrogens and androgens have been shown to possess moderately
active carcinogenic properties (though not the synthetic stilboestrol), and that
oestrogens have in addition a noticeable mitogenic effect on sensitive tissues
(Bullough, 1942 1946, 1950a, 1950b). The final drawback to oestrogen therapy,
apart from its minor side effects, is that the pituitary, after a period of medication,
becomes indifferent to the action of stilboestrol. Indeed, it was shown bv Blur-
roughs and Horning (1947) that if the pituitary is given a prolonged treatment
with oestrogens the anterior lobe as a whole passes into a stage of hyperplasia
having all the characters of an adenoma.
In common with other endocrine glands, the thyroid has a reciprocal relation-
ship with the pituitary. Thus, the gonadotrophic hormone from the pituitary
will stimulate the ovary to produce oestrogen and the blood level of oestrogen so
produced in turn governs the subsequent output ofgonadotrophic hormone, a low
oestrogen level leading to a high output of gonadotrophic hormone and viCe-vr,ersa,
a high oestrogen blood level leading to a low gonadotrophic hormone outplut by the
pituitary. In the same way, a low thyroxine level in the blood will act as a
stimnulus to the pituitary which will put out increased amount of thyrotropic
hormone to stimulate, in its turn, the thyroid; and( conversely, a high thyroxinie
level in the blood has the effect of suppressing the activity ofthe-pituitary. Thus
both oestrogen and thyroxine have a similar action on the pituitary and tend to
suppress its activity, but in addition thyroxine has not been shown to possess any
carcinogenic properties, nor would such activity be expected fromni consideration
of its molecular structure; nor has it been shown that the pituitary eventually
becomes indifferent to its action. Furthermore, the presence of thyroxine in
the tissues, as has already been amply demonstrated in the animal experiments
detailed above, brings about a tissue environment that is unfavourable to tuinour
growth and development, atleastas long as tumours remain in the dependent phase.
In an attempt to explain how this change in tissue is effective we are left with
several possibilities:
(a) That thyroxine encourages normal physiological tissue respiration rathler
than the so-called anaerobic type which appears to be the one demonstrable
biochemical difference between normal and neoplastic tissue (Greenstein, 1947).
(b) That thyroxine in adequate amounts may reverse the process of dedifferen-
tiation or drift towards anaplastic growth that characterises most neoplastic
tissue-the more malignant, the more anaplastic-that is, it may bring abolut
the process of differentiation and development that it certainly does promote in
the embryonic stages and early years of life.
(c) That thyroxine, by raising the nietabolic rate or by mnaintaining it at a
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proper level, brings about some degree of katabolism and/or an increased rate of
excretion ofthe carcinogen.
(d) That thyroxine brings about some depression of pituitary activity. In
this connection, the depolymerisation of connective tissue which seems to be
brought about by excess of thyrotropic hormone (Robb-Smith, 1954) is particu-
larlyrelevantinview oftheimportance which some attach to changes inconnective
tissue in the genesis of malignant disease, for thyroid medication is capable of
reversing the process and of bringing about polymerisation of the mucopolysac-
charides and so a return to a more normal structure of connective tissue.
(e) That the favourable effect of thyroxine in these experiments is due to a
combination of some or all of these factors.
At a recent Imperial Cancer Research Fund lecture at the Royal College of
Surgeons, Professor Hadfield said: "It is my firm belief that for many years we
have been so anxious to discover all we possibly can about the structure of the
growth and its metastases that we have almost forgotten the soil in which it
grows." (Hadfield, 1954.)
In coming to any conclusion regarding the possible association between malig-
nant disease and thyroid function, it cannot be too strongly stressed that a low
metabolic rate or an insufficiency ofthyroid substance can in no way be considered
as a primary cause of cancer. Thyroid and related substances cannot therefore
be considered as a cure for cancer. It is, however, suggested that thyroid function
(or dysfunction) may be associated with the susceptibility or immunity to cancer.
As such, thyroid might well be used as a therapeutic weapon, ancillary only to
accepted surgical treatment, much as antiserum is a valuable ancillary in the
treatment of tetanus or gas gangrene, but in itself is no substitute for radical
surgery in either condition, even though it may rightly be regarded as the factor
which takes suitable surgical toilet out of the realm of debatable value to the
sphere of accepted success under reasonable conditions.
In the wider and perhaps more important field of preventive medicine, the
possibility that an increased susceptibility to cancer occurs in those with a poor
thyroid function leads for the first time to a real chance of adopting prophylactic
measures against cancer on a wide scale. The measures adopted would be in the
main those already available against goitre in the young and in adolescents, with
the idea ofbuilding up healthy activethyroid glands duringtheirperiod ofdevelop-
ment; and in adult life steps would be taken to maintain a good level of thyroid
activity by ensuring that iodine is available in suitable quantities in food and
drink, especially when middle life is reached and there is a natural tendency for
the iodine level to fall (Rundle, 1951). Only in some such way can an immunity
be built up against the many carcinogenic substances which it is virtually impos-
sible to avoid, largely due to the widespread use of coal and oil. In addition, it
must be recalled that there are substances such as cholesterol, vitamin D and the
sex hormones and even sunshine itself, which are all part ofa normal and healthy
existence in spite of their proved capacities to cause cancer, even if they are not
finally shown to be the primary causes of the commonly occurring, non-industrial
neoplasms that formthe bulk ofthe problem ofmalignant disease.
SUMMARY.
Data from fifteen countries in four continents give support to the importance
of local factors to account for the known local variations of cancer incidence.
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Iodine availability, traced by goitre incidence, appears to be one of such factors.
Closer scrutiny of some of these countries corroborates these conclusions.
Clinical findings and a review of some ofthe experimental work available lend
further emphasis to these observations.
The apparent relationship of thyroid insufficiency and the liability to develop
cancer is discussed in connection with such other hormonal influences over cancer
as are already known, particularly in respect of the pituitary.
Lines of investigation and clinical trials have been started, but results of any
value cannot be expected for several years.
A non-specific organ immunity or susceptibility seems to be the simplest
explanation of the facts presented, and the possibilities, preventive and perhaps
therapeutic, that are opened up by this line ofresearch are briefly discussed.
I am indebted to Dr. Polak of Amsterdam for Fig. 1 and for much information
regarding Holland; to Professor McClendon and the Minnesota Press for Fig. 6;
toDr. StocksforFig. 2, 4, and 5 andforadvice andencouragement; totheB.E.C.C.
for permission to publish Fig. 2; to Mr. McEwan for much helpful criticism and
for Fig. 3; to Dr. Williamson for Fig. 8; to Dr. Kelly for Fig. 7 and for much
factual material; and to Mr. Banham for the reproductions of the maps.
I am especially grateful to Dr. G. Price ofthe Bristol Cancer Research Institute
for much kindly advice and, finally, to colleagues at Frenchay and Bristol General
Hospitals for access to many cases under their care.
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